Companies

X4 Pharmaceuticals, Inc (XFOR) SEC filings

CIK 0001501697 · Biological Products, (No Diagnostic Substances) (SIC 2836) · Nasdaq · incorporated in DE · fiscal year ends 12/31

Annual financials (from the company's own XBRL in its 10-K filings)

FY2025FY2024
Revenue (USD)6.5 M
Net income (USD)-79.2 M-93.9 M
Diluted EPS (USD/shares)-1.87-1.52

Latest filings

FiledFormDescriptionPeriod
2026-10-194FORM 42026-10-16
2026-10-088-K8-K items 1.01,1.02,2.03,3.02,7.01,9.012026-10-07
2026-10-07SCHEDULE 13G/ASCHEDULE 13G/A
2026-10-054FORM 42026-10-01
2026-10-01144144
2026-09-21SCHEDULE 13GSCHEDULE 13G
2026-09-098-K8-K items 8.01,9.012026-09-08
2026-09-088-K8-K items 8.01,9.012026-09-08
2026-08-14SCHEDULE 13G/ASCHEDULE 13G/A
2026-08-14SCHEDULE 13G/ASCHEDULE 13G/A
2026-08-134FORM 42026-08-12
2026-08-134FORM 42026-08-12
2026-08-13144144
2026-08-13144144
2026-08-0610-Q10-Q2026-06-30
2026-07-30SCHEDULE 13GSCHEDULE 13G
2026-07-014FORM 42026-06-30
2026-07-014FORM 42026-07-01
2026-07-013FORM 32026-07-01
2026-07-018-K8-K items 5.02,7.01,9.012026-06-30
2026-05-15SCHEDULE 13G/ASCHEDULE 13G/A
2026-05-14EFFECTEFFECT items ,,
2026-05-138-K/A8-K/A items 5.02,5.07,9.012026-05-11
2026-05-134FORM 42026-05-12
2026-05-12144144

Forms on file (last 1,000): 4 256, 8-K 141, 3 59, 144 42, SC 13G/A 37, 10-Q 26, SC 13G 22, CORRESP 19. Source: SEC EDGAR, as filed; this page is public data and not investment advice.

For software and AI agents: the same data as JSON, per call, no account: GET https://store.agentexchange.work/gw/filings/company?ticker=XFOR (0.002 USD), /gw/filings/filings?ticker=XFOR&form=8-K, /gw/filings/facts?ticker=XFOR&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txt

Updated from EDGAR within 30 minutes of a filing. Agent Exchange